DEXA/RMR/VO2 Max/Across the North West
Journal

Grip Strength Testing: A Complete Practical Guide

2 October 2026Updated 4 October 2026

Grip strength testing turns a brief maximal squeeze into a measurable result. That simplicity is useful, but it can also invite overinterpretation. The score describes maximal isometric hand-grip force under a particular protocol. It is not a diagnosis, a complete measure of whole-body strength or a verdict on somebody’s health.

Large studies show why clinicians and researchers remain interested in it. A prospective UK Biobank analysis included 502,293 adults aged 40 to 69 and found that lower grip strength was associated with several adverse health outcomes and all-cause mortality in the BMJ study. Those are population-level associations. They do not prove that a low score caused an illness or that making the number higher will remove the associated risk.

The useful question is therefore not simply, “Is this score good?” It is, “Was the test performed consistently, is the reference appropriate, and does the result fit the person’s age, sex, symptoms, function and previous measurements?”

Table of Contents

Why a Simple Hand Squeeze Matters

Grip dynamometry is quick, portable and inexpensive compared with many laboratory assessments. It can contribute to rehabilitation, geriatric assessment, nutrition review, hand therapy, occupational health and research. Repeated under the same conditions, it can also help track recovery or functional change.

British life-course data show that grip strength rises through childhood, reaches a broad peak in early adulthood, is maintained for a period and then declines from midlife onwards. The study combined 60,803 observations from 49,964 people across 12 general-population studies in Great Britain in the University of Bristol research record. This pattern is why age-specific interpretation matters.

Grip is still only one component of physical capability. A comprehensive fall risk assessment, for example, may need a history, medication and cardiovascular review, gait and balance assessment, vision, home hazards and bone-health context. A dynamometer cannot replace those steps.

Practical rule: treat grip strength as a standardised functional signal. Do not turn it into a stand-alone frailty, diabetes or sarcopenia diagnosis.

What Grip Strength Testing Actually Measures

A hand-grip dynamometer records the force produced during a maximal voluntary isometric contraction. “Isometric” means force is generated without the joints moving through a visible range. Depending on the device, the result may be displayed in kilograms-force, pounds-force or newtons.

The result depends on the person, the equipment and the protocol. The muscles of the hand and forearm generate the grip, while the wrist, elbow, shoulder and trunk help establish a stable position. Pain, unfamiliarity, effort and the tester’s instructions can all influence the value.

What the number really captures

The score is a practical measure of hand-grip force capacity at that moment. It may be reported as the best trial, the mean of several trials, the value from one hand or the highest value from either hand. These are not interchangeable definitions. The scoring rule used for the reference data must match the scoring rule used for the person being tested.

Absolute grip strength is the raw force. Researchers sometimes divide grip strength by body weight or another measure of body size to study relative strength. That can be useful for a defined research question, but a relative value should not be compared directly with an absolute clinical cut-off.

Hand dominance, hand size, age, sex, height and body size can influence results. None of those factors makes the score meaningless. They explain why a universal pass mark is not appropriate and why the testing record needs more than one number.

What it is not

Grip strength is not a direct measure of leg strength, balance, endurance, aerobic capacity, muscle mass or bone density. A person may have a strong grip and impaired lower-limb function, or a low grip score because of local hand pain despite otherwise good physical capacity.

It is also not a diagnosis of sarcopenia. Current European consensus uses low muscle strength to identify probable sarcopenia, then requires evidence of low muscle quantity or quality to confirm it, with poor physical performance used to grade severity in the EWGSOP2 consensus. A grip result belongs inside that clinical pathway rather than replacing it.

Standard Protocols and Common Dynamometers

There is no single posture and scoring rule used in every setting. Two established examples are the American Society of Hand Therapists approach and the Southampton protocol. Both aim to standardise the test, but they differ in chair setup, arm support and how repeated trials are summarised. A systematic review comparing grip protocols shows why the name of the protocol should be recorded rather than reduced to “three squeezes” in the open-access review.

In a commonly used ASHT-style position, the person sits upright with feet supported, the shoulder adducted and neutrally rotated, the elbow at 90 degrees, the forearm neutral and the wrist slightly extended. The Southampton protocol uses a consistent chair, rests the forearms on its arms and positions the wrist just beyond the armrest with the thumb facing upwards.

Neither position should be silently combined with the other’s normative values. Choose a documented protocol, follow it and use reference data collected in a sufficiently similar way.

How the test is usually run

Before testing, explain the task and ask about current pain, recent hand or upper-limb injury, surgery and any reason a maximal squeeze may be inappropriate. Do not test through unusual pain. A person with a recent injury or a clinical restriction needs advice from the relevant healthcare professional.

Then:

  1. Seat and position the person according to the chosen protocol.
  2. Select the device and handle setting required by that protocol.
  3. Check the device according to the manufacturer’s calibration and quality-control instructions.
  4. Demonstrate the task and use the same standardised instruction for every trial.
  5. Complete the prescribed number of trials and rest interval.
  6. Record the hand, device, handle setting, posture, trial values and scoring rule.

A familiarisation attempt can reduce uncertainty about the task, but it must be used consistently. If one visit includes practice and the next does not, the apparent change may partly reflect learning rather than strength.

Some protocols use the mean of three trials; others use the maximum. Some alternate hands, while others complete one side first. Neither approach should be changed halfway through a follow-up series.

Common device types

Device typeWhat it recordsMain interpretation issue
Hydraulic hand dynamometerForce transmitted through a hydraulic mechanismWidely used in clinical research, but calibration, handle position and tester support still matter
Digital force dynamometerForce through an electronic sensorConvenient logging does not make values interchangeable with another model
Pneumatic bulb dynamometerPressure generated while squeezing a bulbPressure-based values should not be read against force norms from a hydraulic device
Spring grip gaugeDeflection or tension in a spring mechanismQuality and calibration vary, so device-specific evidence is essential
Exercise hand gripperTraining resistance rather than a validated measurementNot a substitute for a calibrated clinical dynamometer

A digital display can look precise while still answering a device-specific question. Precision on the screen is not the same as agreement with another instrument.

UK Normative Values and Cut-Offs by Age and Sex

Normative values describe how a reference population performed. A clinical cut-off is a threshold chosen for a specific decision or algorithm. They should not be presented as the same thing.

The British life-course study reported a peak median grip of 51 kg for men between ages 29 and 39 and 31 kg for women between ages 26 and 42. It modelled centile curves rather than the simple decade-by-decade fifth-percentile table sometimes reproduced online. That original table should be consulted if an age-specific centile is needed in the full PLOS ONE paper.

Related work proposed weak-grip cut-offs of 27 kg for men and 16 kg for women. A systematic review found that developed-world norms were broadly similar to the British centiles and explained that about a quarter of people aged 80 were at or below those levels in Age and Ageing. These thresholds were later used in the EWGSOP2 sarcopenia framework, but they are not a diagnosis on their own.

UK reference table

Reference pointMenWomenCorrect use
Peak median in the 12-study British model51 kg, ages 29 to 3931 kg, ages 26 to 42Describes the modelled peak of the reference population, not a target for every adult
British weak-grip cut-off later used by EWGSOP227 kg16 kgValues below the cut-off identify low strength within a sarcopenia case-finding pathway
Modelled proportion at or below the British cut-off at age 8023.0%26.6%Describes a population estimate, not an individual’s probability of disease

The table deliberately does not invent decade-specific fifth percentiles. For a precise age centile, use the study’s actual centile table and reproduce its measurement and scoring approach.

Device-specific values can differ substantially. A UK study of 907 adults created separate age-, sex- and hand-stratified reference values for the GripAble digital dynamometer in the device study. Most authors were employees of the manufacturer and two were patent owners, so the result is useful as device-specific evidence, not as a replacement for all other norms.

Reliability and Sources of Error in Practice

Grip testing can be reliable when the equipment and procedure are controlled. The important phrase is “when controlled”. A change in device, posture, handle setting, instruction or scoring method can create an apparent trend without a real biological change.

What makes scores wobble

Common sources of variation include:

  • changing from seated to standing testing;
  • altering elbow or wrist position;
  • supporting the forearm on one visit but not another;
  • changing the dynamometer or handle setting;
  • using different encouragement or contraction duration;
  • comparing a best trial with an average of trials;
  • testing through hand, wrist, elbow or shoulder pain;
  • fatigue from repeated attempts or recent strenuous gripping;
  • unfamiliarity with the task or misunderstanding the instruction.

Record these details when they are present. A surprising result should first trigger a protocol check and a conversation about symptoms, not an instant conclusion about health decline.

Why the device matters

Two instruments can be individually reliable yet disagree with each other. Their handle geometry, sensing mechanism, units and calibration can all change the reading. Use the same device for serial testing where possible. If the equipment changes, begin a newly documented series or use a validated conversion only if one exists for those exact models.

Commercial service pages are not measurement standards. The protected ELITE Performance Test Bundle link is a current commercial route for a bundle of other physiological tests. It does not provide a grip-strength protocol, a normative dataset or evidence for a repeat-testing interval, so it should not be used to support any of those claims.

Clinical and Performance Implications

Grip strength is associated with health outcomes at population level, but association is not diagnosis or causation. In a UK Biobank analysis of 166,894 participants, 3,713 developed type 2 diabetes over a median 5.3 years. Compared with the highest age- and sex-specific quintile of absolute grip strength, the lowest quintile was associated with a 50% higher risk in men and a 25% higher risk in women in the published cohort study.

That study was observational, the UK Biobank is not fully representative of the UK population, and residual confounding or reverse causation may remain. The authors explicitly called for further work before grip is added to diabetes risk scores. A low reading cannot diagnose diabetes and should never replace established risk assessment or blood testing.

The same caution applies to the large BMJ outcome study. Lower grip was associated with mortality and several cardiovascular, respiratory and cancer outcomes, but adding grip produced only small changes in the discrimination of an office-based risk model. The finding supports further assessment and research, not a promise that one squeeze predicts an individual’s future.

How clinicians use the signal

The clinical use depends on the question:

  • Local hand or upper-limb function: compare sides and follow recovery using a relevant hand-therapy or rehabilitation protocol.
  • Probable sarcopenia: low grip may establish low muscle strength, which then needs confirmation of low muscle quantity or quality and assessment of physical performance under an appropriate clinical pathway.
  • Nutrition or frailty review: use grip alongside history, weight change, function and other measures rather than as a stand-alone label.
  • Longitudinal monitoring: compare like with like and investigate a sustained decline rather than overreacting to one noisy trial.

Low muscle strength together with low appendicular muscle quantity may support confirmed sarcopenia under EWGSOP2, but neither result explains the cause. Illness, undernutrition, inactivity, neurological disease, pain and other factors may need consideration. The sarcopenia prevention guide offers broader educational context, while suspected sarcopenia warrants appropriate clinical assessment.

For sport and work, relevance is task-specific. Grip can be directly useful in climbing, racket sports, grappling, manual work and rehabilitation of the hand or forearm. It is a poor stand-alone forecast for running, cycling, lower-body power or aerobic conditioning. Evidence does not support using one daily grip value as a universal measure of recovery or “training readiness”.

A Practical Testing Checklist for Clinics, Gyms and Workplaces

The setting changes the purpose, but it should not lower the measurement standard. A rapid workplace screen still needs a stated protocol. A gym trend still needs consistent equipment. A clinical test still needs interpretation in the context of symptoms and function.

A copy-and-use checklist

  • Define the purpose. Rehabilitation, case-finding, research and training monitoring need different reference data and decisions.
  • Choose the protocol. Name the ASHT, Southampton or other validated method and keep its posture, trials and scoring rule intact.
  • Check suitability. Ask about current pain, recent injury or surgery and any restriction on maximal effort. Stop if unusual pain occurs.
  • Identify the device. Record manufacturer, model, serial or asset identifier, units and handle setting where relevant.
  • Control the position. Record chair, feet, shoulder, elbow, forearm, wrist and whether the device or arm was supported.
  • Standardise the instruction. Use the same explanation and encouragement for every trial and visit.
  • Record every trial. Keep the raw values, hand tested, rest interval and the rule used to calculate the reported score.
  • Match the reference. Use norms collected with a comparable device, protocol, population and summary method.
  • Interpret, do not label. Explain uncertainty and refer when the result conflicts with symptoms, function or the wider assessment.

How the environment changes the emphasis

In a hand clinic or rehabilitation service, side-to-side comparison and change after injury may be central, so pain, affected side and treatment stage need recording. In older-person assessment, grip may contribute to sarcopenia or frailty case-finding, but chair-rise performance, walking, nutrition and medical history may be equally important.

In a gym, a calibrated measurement device should not be confused with an exercise gripper. If the goal is trend tracking, perform the test before a similar type of session, under comparable conditions and without turning small day-to-day fluctuations into training decisions.

In occupational health or a workplace event, avoid presenting a threshold as a fitness-for-work verdict unless a validated occupational pathway specifically supports that decision. Screening should explain what the test can and cannot show and how an unexpected result will be followed up.

Reading Your Result and Where Grip Fits Alongside DEXA, VO2 Max and RMR

A grip score answers a different question from body composition, aerobic-capacity and resting-metabolism tests.

TestPrimary measurementWhat it cannot establish alone
Grip dynamometryMaximal voluntary isometric hand-grip forceWhole-body strength, muscle mass, aerobic fitness or a diagnosis
DEXA or DXABone mineral content or density, lean soft tissue and fat mass, depending on scan and analysisFunctional strength, the cause of low muscle quantity or complete osteoporosis assessment from body composition alone
VO2 max testingOxygen uptake during graded exercise, subject to appropriate maximal or verification criteriaHand strength, muscle quantity or resting energy needs
RMR testingResting energy expenditure under controlled conditionsTotal daily energy expenditure, strength or aerobic capacity

The tests may complement one another when there is a genuine clinical or physiological question. They are not a package that automatically becomes necessary after one low grip result.

How to read the number in context

Ask five questions before interpreting the score:

  1. Was the protocol valid? Check position, device, handle setting, trials and scoring rule.
  2. Is the comparison appropriate? Match age, sex, device and protocol rather than selecting the most convenient online table.
  3. Is there a local explanation? Pain, injury, arthritis or neurological symptoms may affect one or both hands.
  4. Does it fit function? Consider daily tasks, chair rise, walking, falls, training and occupational demands.
  5. Is there a reliable trend? A sustained change measured consistently is more informative than one isolated result.

DEXA-derived appendicular lean mass may contribute to a clinical sarcopenia assessment, but DEXA uses ionising radiation and requires proper governance. Every Telomyx DEXA enquiry uses a medical questionnaire, requires a referral and is individually justified by an entitled practitioner. An initial interest may relate to body composition, weight management, fitness or sports performance, but that interest is not the clinical justification and does not guarantee a scan. If the person is unsuitable or the exposure cannot be medically justified, Telomyx does not issue the referral or perform the scan. Pregnancy status is screened where relevant.

This pathway reflects the requirement for individual justification under IR(ME)R guidance and the current UK government position on DEXA. The Telomyx DEXA service page describes the measurements available, but a scan remains subject to screening, referral, justification and suitability.

When to act on the result

Arrange appropriate clinical review when a low or falling grip score accompanies unexplained weight loss, reduced appetite, repeated falls, difficulty with daily activities, progressive weakness, persistent pain, numbness or other neurological symptoms. The next step may be a repeat standardised measurement, examination, medication or nutrition review, physiotherapy, occupational therapy, or investigation of an underlying condition.

Sudden weakness or numbness on one side, particularly with facial droop or speech difficulty, is not a routine grip-testing question. Follow the NHS FAST stroke guidance and call 999, even if the symptoms improve.

If the result is unexpected but there are no concerning symptoms, check the protocol first and repeat it under comparable conditions. Do not self-diagnose sarcopenia, diabetes or frailty from a consumer dynamometer.

Telomyx does not list grip dynamometry as one of its tests. Its current services measure body composition and bone-related data, aerobic capacity and resting energy expenditure. The protected clinical assessment services overview explains those separate measurement domains, and current service information is available from Telomyx. Neither page replaces clinical assessment of an unexplained low grip result.

The most useful grip score is therefore not the largest number. It is a repeatable measurement, collected with a documented protocol, interpreted against an appropriate reference and connected to the right next question.

The content in this article is for educational purposes only and does not constitute medical or dietary advice. If you have an underlying health condition, are taking medication, or are considering significant changes to your diet or exercise regimen, consult a qualified healthcare professional before making any adjustments.

Profile photo of Dr Alex Trevatt, Telomyx Clinical Lead
Reviewed and written by

Telomyx Clinical Lead. Medical and scientific review, evidence checks and Telomyx service accuracy.

From £140

Put the reading into practice